Arun P. Thottumkara

Person

Menlo Park, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Kinase inhibitors and uses thereof
- Patent number 12,129,263
- Issue date Oct 29, 2024
- Denali Therapeutics Inc.
- Javier De Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions and methods
- Patent number 12,091,392
- Issue date Sep 17, 2024
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions and methods
- Patent number 11,958,840
- Issue date Apr 16, 2024
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
C26-linked rapamycin analogs as mTOR inhibitors
- Patent number 11,685,749
- Issue date Jun 27, 2023
- Revolution Medicines, Inc.
- Christopher Michael Semko
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions and methods
- Patent number 11,306,077
- Issue date Apr 19, 2022
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors and uses thereof
- Patent number 11,203,600
- Issue date Dec 21, 2021
- Denali Therapeutics Inc.
- Javier De Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions and methods
- Patent number 11,072,618
- Issue date Jul 27, 2021
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
- Patent number 10,980,889
- Issue date Apr 20, 2021
- Revolution Medicines, Inc.
- Jennifer Pitzen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives of amphotericin B
- Patent number 10,882,883
- Issue date Jan 5, 2021
- Sfunga Therapeutics, Inc.
- Martin D. Burke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives of amphotericin B
- Patent number 10,597,420
- Issue date Mar 24, 2020
- Sfunga Therapeutics, Inc.
- Martin D. Burke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of amphotericin B
- Patent number 9,957,290
- Issue date May 1, 2018
- Sfunga Therapeutics, Inc.
- Martin D. Burke
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20240391932
- Publication date Nov 28, 2024
- Nico Therapeutics, Inc.
- Robert A. Craig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20240254132
- Publication date Aug 1, 2024
- Denali Therapeutics Inc.
- Alex L. Bagdasarian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C26-LINKED RAPAMYCIN ANALOGS AS MTOR INHIBITORS
- Publication number 20240166667
- Publication date May 23, 2024
- Revolution Medicines, Inc.
- Christopher Michael SEMKO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS, AND METHODS
- Publication number 20230416205
- Publication date Dec 28, 2023
- Denali Therapeutics Inc.
- Alex L. Bagdasarian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20230357162
- Publication date Nov 9, 2023
- Denali Therapeutics Inc.
- Alex L. Bagdasarian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20230348437
- Publication date Nov 2, 2023
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF EUKARYOTIC INITIATION FACTOR 2
- Publication number 20230250072
- Publication date Aug 10, 2023
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20230114472
- Publication date Apr 13, 2023
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RAPAMYCIN ANALOGS AS MTOR INHIBITORS
- Publication number 20230093861
- Publication date Mar 30, 2023
- Revolution Medicines, Inc.
- James Bradley AGGEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR Inhibitors
- Publication number 20230055672
- Publication date Feb 23, 2023
- Revolution Medicines, Inc.
- Jennifer Pitzen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
C26-LINKED RAPAMYCIN ANALOGS AS MTOR INHIBITORS
- Publication number 20220340596
- Publication date Oct 27, 2022
- Revolution Medicines, Inc.
- Christopher Michael SEMKO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20220177438
- Publication date Jun 9, 2022
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20220177456
- Publication date Jun 9, 2022
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase Inhibitors and Uses Thereof
- Publication number 20220041620
- Publication date Feb 10, 2022
- Denali Therapeutics Inc.
- Javier De Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR Inhibitors
- Publication number 20210338824
- Publication date Nov 4, 2021
- Revolution Medicines, Inc.
- Jennifer Pitzen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds, Compositions and Methods
- Publication number 20210332058
- Publication date Oct 28, 2021
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20210292311
- Publication date Sep 23, 2021
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF EUKARYOTIC INITIATION FACTOR 2
- Publication number 20210130308
- Publication date May 6, 2021
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RAPAMYCIN ANALOGS AS MTOR INHIBITORS
- Publication number 20210094975
- Publication date Apr 1, 2021
- Revolution Medicines, Inc.
- James Bradley AGGEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF AMPHOTERICIN B
- Publication number 20200262858
- Publication date Aug 20, 2020
- Sfunga Therapeutics, Inc.
- Martin D. Burke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase Inhibitors and Uses Thereof
- Publication number 20200087319
- Publication date Mar 19, 2020
- Denali Therapeutics Inc.
- Javier De Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR Inhibitors
- Publication number 20190336609
- Publication date Nov 7, 2019
- Revolution Medicines, Inc.
- Jennifer Pitzen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds, Compositions and Methods
- Publication number 20190300537
- Publication date Oct 3, 2019
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF AMPHOTERICIN B
- Publication number 20180273572
- Publication date Sep 27, 2018
- Sfunga Therapeutics, Inc.
- Martin D. Burke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Derivatives of Amphotericin B
- Publication number 20160304548
- Publication date Oct 20, 2016
- Revolution Medicines, Inc.
- Martin D. Burke
- C07 - ORGANIC CHEMISTRY

Arun P. Thottumkara

Person

Patents Grantslast 30 patents

Kinase inhibitors and uses thereof

Compounds, compositions and methods

Compounds, compositions and methods

C26-linked rapamycin analogs as mTOR inhibitors

Compounds, compositions and methods

Kinase inhibitors and uses thereof

Compounds, compositions and methods

C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors

Derivatives of amphotericin B

Derivatives of amphotericin B

Derivatives of amphotericin B

Patents Applicationslast 30 patents

COMPOUNDS, COMPOSITIONS AND METHODS

COMPOUNDS, COMPOSITIONS AND METHODS

C26-LINKED RAPAMYCIN ANALOGS AS MTOR INHIBITORS

COMPOUNDS, COMPOSITIONS, AND METHODS

COMPOUNDS, COMPOSITIONS AND METHODS

COMPOUNDS, COMPOSITIONS AND METHODS

MODULATORS OF EUKARYOTIC INITIATION FACTOR 2

COMPOUNDS, COMPOSITIONS AND METHODS

RAPAMYCIN ANALOGS AS MTOR INHIBITORS

C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR Inhibitors

C26-LINKED RAPAMYCIN ANALOGS AS MTOR INHIBITORS

COMPOUNDS, COMPOSITIONS AND METHODS

COMPOUNDS, COMPOSITIONS AND METHODS

Kinase Inhibitors and Uses Thereof

C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR Inhibitors

Compounds, Compositions and Methods

COMPOUNDS, COMPOSITIONS AND METHODS

MODULATORS OF EUKARYOTIC INITIATION FACTOR 2

RAPAMYCIN ANALOGS AS MTOR INHIBITORS

DERIVATIVES OF AMPHOTERICIN B

Kinase Inhibitors and Uses Thereof

C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR Inhibitors

Compounds, Compositions and Methods

DERIVATIVES OF AMPHOTERICIN B

Derivatives of Amphotericin B